A randomized controlled trial of mirabegran and fesoterodine in overactive bladder
Not Applicable
- Conditions
- overactive bladder
- Registration Number
- JPRN-UMIN000038196
- Lead Sponsor
- Dokkyo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
patients with a history of hypersensitivity to fesoterodine or mirabegron
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method total score of overactive bladder symptom score
- Secondary Outcome Measures
Name Time Method each score of overactive bladder symptom score, total score of overactive bladder symptom score international prostate symptom score, total score of King's Health Questionnaire, frequency volume chart, urofluometry, residual urine